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Fla; DObjectives: The purpose of this analysis was to assess preoperative risk factors before the first-stage Norwood
procedure in infants with hypoplastic left heart syndrome and related single-ventricle lesions and to evaluate
practice patterns in prenatal diagnosis, as well as the role of prenatal diagnosis in outcome.
Methods: Data from all live births with morphologic single right ventricle and systemic outflow obstruction
screened for the Pediatric Heart Network’s Single Ventricle Reconstruction Trial were used to investigate prenatal
diagnosis and preoperative risk factors. Demographics, gestational age, prenatal diagnosis status, presence of
major extracardiac congenital abnormalities, and preoperative mortality rates were recorded.
Results:Of 906 infants, 677 (75%) had prenatal diagnosis, 15%were preterm (<37 weeks’ gestation), and 16%
were low birth weight (<2500 g). Rates of prenatal diagnosis varied by study site (59% to 85%, P<.0001). Ma-
jor extracardiac congenital abnormalities were less prevalent in those born after prenatal diagnosis (6% vs 10%,
P¼ .03). There were 26 (3%) deaths before Norwood palliation; preoperative mortality did not differ by prenatal
diagnosis status (P ¼ .49). In multiple logistic regression models, preterm birth (P ¼ .02), major extracardiac
congenital abnormalities (P< .0001), and obstructed pulmonary venous return (P ¼ .02) were independently
associated with preoperative mortality.
Conclusions: Prenatal diagnosis occurred in 75%. Preoperative death was independently associated with preterm
birth, obstructed pulmonary venous return, and major extracardiac congenital abnormalities. Adjusted for gesta-
tional age and the presence of obstructed pulmonary venous return, the estimated odds of preoperative mortality
were 10 times greater for subjects with a major extracardiac congenital abnormality. (J Thorac Cardiovasc Surg
2010;140:1245-50)Diagnosis of congenital heart disease with fetal echocardiog-
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D been that prenatal diagnosis should improve outcome, but
most studies have not demonstrated an improvement in post-
operative survival with prenatal diagnosis.5,6 A single study
found that prenatal diagnosis was associated with improved
preoperative clinical status and improved survival after the
first-stage reconstruction (the Norwood procedure).7 Consid-
erable effort has been expended to identify risk factors for
postoperative mortality after Norwood palliation.8,9
However, some infants die before reaching the operating
room, and risk factors for preoperative mortality and
potential associations among prenatal diagnosis, patients’
characteristics, and preoperative mortality are poorly
understood. The aims of this investigation were to describe
the following:
 current prevalence and timing of diagnosis (prenatal
vs postnatal) in a large, contemporary multicenter co-
hort of patients with HLHS or related morphologic
single right ventricular lesions with systemic outflow
obstruction;
 center-level variation in the rate of prenatal diagnosis;
 patients’ characteristics associated with prenatal diag-
nosis; and
 determinants of preoperative mortality, including
patients’ characteristics and prenatal diagnosis.MATERIALS AND METHODS
Design of the Single Ventricle Reconstruction Trial
Data for the analyses were obtained as part of a screening protocol used
in a multicenter randomized trial of modified Blalock–Taussig shunt versus
right ventricular–pulmonary artery shunt introduced during a stage I pallia-
tion (Norwood) procedure. All live births with a diagnosis of a single mor-
phologic right ventricle with systemic outflow obstruction were eligible for
inclusion in the trial. The trial’s primary outcome measure was the compos-
ite proportion of subjects experiencing death or cardiac transplantation 12
months after randomization. The design of this trial, conducted by the Na-
tional Heart, Lung, and Blood Institute–funded Pediatric Heart Network has
been previously described.10 From May 2005 to July 2009, 15 centers
enrolled 555 subjects (ClinicalTrials.gov number: NCT00115934).
The protocol was approved by an independent protocol review commit-
tee and data and safety monitoring board, by institutional review boards at
each clinical center, and at the data coordinating center. all centers followed
the same protocol and study procedures.
Screening of Potential Subjects
During the enrollment period, all neonates with amorphologic single right
ventricle and systemic outflow obstruction admitted to participating centers
were assessed for inclusion in the trial. Data collected at screening included
birth weight, race, sex, gestational age, fetal intervention (atrial septostomy
or aortic valve dilation), detailed cardiac diagnosis, presence of major extrac-
ardiac congenital abnormalities or acquired extracardiac disorders, and pres-
ence of and age at prenatal diagnosis. For the purposes of this study,1246 The Journal of Thoracic and Cardiovascular Surobstructed pulmonary venous returnwas defined by the use of postnatal inter-
vention, including balloon septostomy, open atrial septectomy, or urgent
Norwood procedure. Preoperative mortality was also recorded.
For the purposes of analysis, extracardiac congenital abnormalities were
divided into chromosomal and nonchromosomal abnormalities. Chromo-
somal abnormalities included trisomies 13, 18, and 21; Turner’s syndrome,
Ellis–van Creveld syndrome; Goldenhar syndrome; Scimitar syndrome;
Jacobsen syndrome; and other unidentified chromosomal abnormalities or
genetic syndromes. Nonchromosomal abnormalities included acquired
extracardiac disorders (eg, meconium aspiration with need for high-
frequency ventilation and persistent renal failure requiring dialysis) that
the site investigator considered could independently affect the likelihood
of the subject meeting the primary end point of death or transplantation at
1 year.10
Analytic Sample and Statistical Analyses
Statistical analyses were performed with SAS software version 9.2 (SAS
Institute, Inc, Cary, NC) and the R System, version 2.8.1 (R Foundation for
Statistical Computing, Vienna, Austria). Exploratory analyses incorporating
graphic and tabular displays were used to assess bivariate associations.
Sample means, medians, and proportions accompanied by 95% confidence
intervals were used to provide descriptive summaries. c2 Tests of equality of
proportions and Fisher’s exact and Student’s t tests of equality of means
were used to formally test hypotheses of no differences in various factors
versus prenatal diagnosis status. Simple and multiple logistic regressions
were used to assess the relative strength of association between multiple
risk factors and preoperative death. Backwards covariate selection with
a significance criterion of 0.05 was used to construct the multivariate logistic
regression model. Analysis of variance and c2 statistics were used to assess
the degree of cross-center variation in the proportion of subjects with prena-
tal diagnosis and, among those subjects with prenatal diagnosis, fetal gesta-
tional age at that time. An adjusted screening population size was used for 2
centers that had abridged screening periods of participation to obtain center
volume estimates based on total trial duration.RESULTS
Characteristics Associated With Prenatal Diagnosis
From May 2005 to July 2009, 15 centers screened 921 ne-
onates for the Single Ventricle Reconstruction Trial; 15 were
determined to not meet the study entry criteria of morpho-
logic single right ventricle with systemic outflow obstruction
and were excluded, leaving a total of 906 subjects for this
analysis. Prenatal diagnosis was made in 677 (75%) of 906
subjects. Unadjusted associations between subjects’ risk
factors and prenatal diagnosis are presented in Table 1. The
sex and racial/ethnic distributions of subjects with and
without prenatal diagnosis were similar. Although the propor-
tion of preterm infants did not differ based on prenatal
diagnosis status, subjects without a prenatal diagnosis were
on average born at a higher gestational age than those with
a prenatal diagnosis (mean, 0.4 weeks; P ¼ .01; Figure 1).
Thirty-seven subjects did not have specific gestational age re-
ported but were classified as full term. These subjects were
assigned the median gestational age among all subjects
who were not preterm and whose gestational age was
reported (38 weeks). Subjects without prenatal diagnosis
exhibited a greater prevalence of nonchromosomal extracar-
diac congenital abnormalities in comparison with subjects
with prenatal diagnosis (9% vs 4%, P ¼ .01). Fetalgery c December 2010
TABLE 1. Demographic factors and other descriptors by prenatal
status
Prenatal diagnosis,
no. (%)* or mean ± SD
Yes (n ¼ 677) No (n ¼ 228) P value*
Female sex 265 (39) 85 (37) .64
Race
White 528 (78) 169 (74) .59
Black/African American 99 (15) 37 (16)
Asian 16 (3) 6 (3)
Other 34 (5) 16 (7)
Ethnicity .28
Hispanic 117 (17) 49 (21)
Non-Hispanic 537 (80) 174 (76)
Unknown 23 (3) 5 (2)
Major extracardiac congenital
abnormalityy (n ¼ 904)
38 (6) 22 (10) .03
Chromosomal* 10 (1) 2 (1) .74x
All other* 28 (4) 20 (9) .01
Gestational agez (wk) 37.8  1.8 38.2  2.0 .01
Preterm 100 (15) 31 (14) .66
Low birth weight (<2500 g) 115 (17) 31 (14) .23
Birth weight (g) 3038  578 3081  579 .34
SD, Standard deviation. *c2 Test or Student’s t test (no equal variance assumption).
yOne subject with ‘‘unknown’’ diagnostic status has been excluded. z‘‘Full-term’’
patients with unknown gestational age were assigned a gestational age of 38 weeks.
xFisher’s exact test.
FIGURE 1. Kernel density estimates of gestational age according to pre-
natal diagnosis (Dx) status.
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Dintervention on the atrial septum or aortic valve was reported
in 26 (3%) of the screened subjects. There were no differ-
ences in demographic factors, birth characteristics, presence
of major extracardiac abnormalities, or incidence of preoper-
ative death between those with fetal intervention and the re-
mainder of the cohort.Center-Level Variation
There was significant center-level variation in the propor-
tion of subjects with prenatal diagnosis, ranging from 59%
to 85% (P< .0001, Figure 2). The positive association be-
tween the size of the center’s available screening population
and the proportion of subjects with prenatal diagnosis is ap-
parent. There was also significant center-level variation in
mean fetal gestational age at diagnosis (range, 20.6-29.5
weeks; P ¼ .01).FIGURE 2. Center-specific proportions of subjects with prenatal diagnosis
versus number of subjects screened (n ¼ 906). The 15 trial centers are dis-
played as circular symbols sized in relative proportion to the square root of
their respective sample sizes.Risk Factors for Preoperative Mortality
There were 26 (3%) preoperative deaths. Univariable and
multivariable associations between risk factors and preoper-
ative death are presented in Table 2. Subjects who died be-
fore the Norwood procedure had significantly lower
gestational age and birth weight and a much higher rate of
extracardiac congenital anomalies compared with subjects
who survived to the Norwood procedure. In addition, ob-
structed pulmonary venous return was more common among
nonsurvivors (23% vs 5%, P ¼ .002).The Journal of Thoracic and CarIn multivariate logistic regression modeling, only major
extracardiac congenital abnormalities, gestational age, and
the presence or absence of obstructed pulmonary venous re-
turn remained significantly associated with preoperative
mortality (Table 2). The presence of a noncardiac major con-
genital abnormality was most strongly associated with pre-
operative mortality (P < .0001). The estimated odds ofdiovascular Surgery c Volume 140, Number 6 1247
TABLE 2. Associations between risk factors and preoperative death
Unadjusted associations Multivariate model*
Yes (n ¼ 26) No (n ¼ 880) P valuey Odds ratio (95% CI) P value
Prenatal diagnosis 18 (69%) 659 (75%) 0.51
Major extracardiac congenital
abnormality
12 (46%) 48 (6%) <.0001 10.0 (4.0–24.7) <.0001
Chromosomal 1 (4%) 11 (1%) .29
All other 11 (44%) 37 (4%) <.0001
Gestational age (wk), mean  SD 36  3 38  2 .003 1.3 (1.1–1.5) .02
Low birth weight (<2500 g) 11 (42%) 136 (16%) <.001
Aortic atresia 16 (62%) 530 (60%) .90
Obstructed pulmonary venous return 6 (23%) 44 (5%) .002 4.0 (1.3–12.3) .02
CI, Confidence interval; SD, standard deviation. *Multiple logistic regression (n¼ 905). Only risk factors displaying significant univariate association with mortality are included.
yc2 Test of equal proportions.
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Dpreoperative mortality were 10 times greater for subjects
with an extracardiac major congenital abnormality (95%
confidence interval, 4.1–24.8) after controlling for gesta-
tional age and obstructed pulmonary venous return. Prenatal
diagnosis was not a significant correlate of outcome when
added to this model.DISCUSSION
The Single Ventricle Reconstruction Trial included
systematic prospective screening data on the largest contem-
porary cohort of neonates with HLHS and related single
right ventricular lesions with systemic outflow obstruction
to date. This has permitted an unprecedented assessment
of the timing and occurrence of prenatal diagnosis and risk
factors for preoperative death.Characteristics Associated With Prenatal Diagnosis
In contrast to data reported less than a decade agowith rates
of prenatal diagnosis of less than 50%,6,11 the majority
(75%) of neonates screened for this trial had a prenatal
diagnosis. These infants were born at a significantly lower
gestational age than subjects given diagnoses postnatally.
However, although no difference was shown between
diagnostic groups in the percentage born preterm
(37 weeks’ gestation), a considerably higher proportion of
subjects in the postnatal diagnosis group were born at
39 weeks’ gestation or later. The manner of delivery of
subjects (natural labor, planned induction, or scheduled
cesarean section) was not collected; however, we speculate
that the overall difference in gestational age likely reflects
a higher rate of planned induction of labor before
40 weeks’ gestation among the prenatal diagnosis group.
There is increasing appreciation of the association of ex-
tracardiac and chromosomal abnormalities and congenital
heart disease.12,13 In our study major extracardiac
congenital abnormalities occurred less frequently in the
prenatal diagnosis group than in the postnatal diagnosis
group (6% vs 10%, P ¼ .03), but interestingly, this1248 The Journal of Thoracic and Cardiovascular Surdifference was driven by nonchromosomal anomalies
because the proportion of chromosomal anomalies was
similar in both groups. Zyblewski and colleagues14 reported
that women were 14 times more likely to terminate a preg-
nancy or seek comfort care for a fetus with congenital heart
disease if a chromosomal abnormality was present. By
extension, the presence of extracardiac structural anomalies
diagnosed during prenatal ultrasound might also influence
parental treatment decisions. The lack of association
between chromosomal anomalies and prenatal diagnosis in
our study might be explained by a low rate of prenatal kar-
yotyping in this cohort; however, this is speculation because
this information was not collected. We have observed in
clinical practice that despite strong physician recommenda-
tions in favor of prenatal karyotyping, many women decline
amniocentesis out of concern of potential risk to the preg-
nancy.14 It is important to note that differences in pregnancy
termination rates in those with and without prenatal identifi-
cation of more severe pathology might confound the associ-
ation between prenatal diagnosis and preoperative mortality.Center-Level Variation
Rates of prenatal diagnosis and timing (gestational age) of
those diagnoses varied significantly by center. Figure 2 sug-
gests a positive relationship between the number of subjects
per site and the proportion of prenatal diagnoses. It seems
plausible that patients receiving prenatal diagnoses whose
parents have decided in favor of neonatal surgical palliation
might be referred preferentially to large tertiary care centers
with established fetal cardiology practices and well-known
pediatric cardiac surgical programs. Center-level variation
in gestational age at diagnosis could also be influenced by
center variations in the number of patients choosing preg-
nancy termination or postnatal compassionate care only.Risk Factors for Preoperative Mortality
Reports concerning the incidence and characteristics of
preoperative mortality among infants with HLHS andgery c December 2010
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4 (1.8%) of 216 such subjects had preoperative death in a sin-
gle-center series. In this multicenter cohort we found that 3%
died before surgical intervention. Infants with a major extrac-
ardiac congenital anomaly had a 10-fold higher risk of preop-
erative death, largely because of the presence of
nonchromosomal anomalies. This finding is consistent with
previous reports.15 Previous reports suggest a positive rela-
tionship between prenatal diagnosis and improved preopera-
tive management in patients with HLHS.7,16,17 However, we
found no association between prenatal diagnosis and
preoperative mortality. It is possible that improved
education in neonatal units about the risks of ductal-
dependent congenital heart disease in neonates has resulted
in earlier recognition of those not prenatally diagnosed. How-
ever, the inverse relationship between prenatal diagnosis and
extracardiac congenital abnormalities found in the current
study might confound the analysis of any relationship be-
tween prenatal diagnosis and preoperative mortality.
Low birth weight is frequently mentioned in clinical dis-
cussions as a risk factor for surgical outcome, a view borne
out in an analysis of data on several types of congenital
heart operations from the Society of Thoracic Surgeons
Congenital Heart Database.18 Therefore we were surprised
by the finding that gestational age, but not birth weight,
was a significant predictor of preoperative mortality in
multivariable analyses. We know from a recent analysis
of growth parameters in the population screened for the
Pediatric Heart Network’s randomized controlled trial of
enalapril versus placebo in infants with single-ventricle
physiology that there is a significantly higher rate of growth
retardation in infants with single-ventricle physiology com-
pared with that seen in the general population.19 This
suggests that, at a given gestational age, infants with
single-ventricle physiology are smaller than infants with
normal hearts. The physiological maturation implicit in
increased gestational age might be more significant for fetal
and neonatal well-being than size per se. The association
between lower gestational age and increased mortality after
infant heart surgery supports the importance of gestational
age.20 This finding deserves further evaluation and consid-
eration in risk stratification scores.
Obstructed pulmonary venous return is a well-known risk
factor for postoperative mortality after the Norwood proce-
dure.9 We found this also to be a risk factor for preoperative
mortality. Moreover, our findings are consistent with previ-
ous studies that showed no benefit of prenatal diagnosis of
atrial level restriction on outcome.21 Invasive decompres-
sion of the left atrium in fetuses with HLHS and a restrictive
atrial septum has been reported22; whether this strategy will
improve outcomes remains to be seen.
The limitations of this study are primarily related to poten-
tial selection bias. Only live subjects born at or referred to
one of the 15 participating surgical centers were included.The Journal of Thoracic and CarThese centers might not be representative of all centers
performing complex neonatal surgery in North America.
In addition, within the 15 trial centers, selection bias might
have occurred as a result of variation in pregnancy termina-
tion after prenatal diagnosis. More detailed information on
the causes of preoperative death was not available, and
therefore some deaths might have been related to decisions
not to pursue intervention. Finally, this study is restricted
to events occurring before the Norwood procedure; assess-
ment of the effect of prenatal diagnosis on postoperative
survival and other outcomes awaits trial completion.
SUMMARY
Using prospective screening data on the largest contempo-
rary cohort of neonates with HLHS and related single right
ventricular lesions to date, we found that prenatal diagnosis
by means of fetal echocardiographic analysis occurred in
75%. Nonchromosomal major congenital anomalies were
less common among those with a prenatal diagnosis. Preop-
erative death occurred in 3% of subjects and was indepen-
dently associated with preterm birth, obstructed pulmonary
venous return, and major extracardiac congenital abnormali-
ties. Adjusted for gestational age and the presence or absence
of obstructed pulmonary venous return, the estimated odds of
preoperativemortality were 10 times greater for subjects with
a major extracardiac congenital abnormality.
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